Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?

Ma X, Ma C, Zheng X.

Heart Lung Circ. 2013 Oct;22(10):811-8. doi: 10.1016/j.hlc.2013.05.651. Epub 2013 Jul 1. Review.

PMID:
23827206
2.

MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?

Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):449-54. doi: 10.1161/ATVBAHA.112.300279. Epub 2013 Jan 16. Review.

3.

MicroRNAs: important modulators of oxLDL-mediated signaling in atherosclerosis.

Zhang E, Wu Y.

J Atheroscler Thromb. 2013;20(3):215-27. Epub 2012 Oct 13. Review.

4.

Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.

Liu X, Cheng Y, Yang J, Qin S, Chen X, Tang X, Zhou X, Krall TJ, Zhang C.

J Am Heart Assoc. 2013 Oct 28;2(6):e000407. doi: 10.1161/JAHA.113.000407.

5.

Pathogenic arterial remodeling: the good and bad of microRNAs.

Wei Y, Schober A, Weber C.

Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1050-9. doi: 10.1152/ajpheart.00267.2012. Epub 2013 Feb 8. Review.

6.

MicroRNAs in arterial remodelling, inflammation and atherosclerosis.

Weber C, Schober A, Zernecke A.

Curr Drug Targets. 2010 Aug;11(8):950-6. Review.

PMID:
20415650
7.

Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells.

Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C.

J Biol Chem. 2009 Mar 20;284(12):7903-13. doi: 10.1074/jbc.M806920200. Epub 2009 Jan 21.

8.

MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.

Xu Z, Han Y, Liu J, Jiang F, Hu H, Wang Y, Liu Q, Gong Y, Li X.

Sci Rep. 2015 Jul 17;5:12276. doi: 10.1038/srep12276.

9.

MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A.

Zhang Y, Chen B, Ming L, Qin H, Zheng L, Yue Z, Cheng Z, Wang Y, Zhang D, Liu C, Bin W, Hao Q, Song F, Ji B.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14401-8. eCollection 2015.

10.

Role of microRNAs in endothelial inflammation and senescence.

Qin B, Yang H, Xiao B.

Mol Biol Rep. 2012 Apr;39(4):4509-18. doi: 10.1007/s11033-011-1241-0. Epub 2011 Sep 28. Review.

PMID:
21952822
11.

Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation.

Karagiannis GS, Weile J, Bader GD, Minta J.

BMC Cardiovasc Disord. 2013 Jan 16;13:4. doi: 10.1186/1471-2261-13-4.

12.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
13.

Vascular microRNAs.

Bonauer A, Boon RA, Dimmeler S.

Curr Drug Targets. 2010 Aug;11(8):943-9. Review.

PMID:
20415654
14.

MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.

Wang J, Yan CH, Li Y, Xu K, Tian XX, Peng CF, Tao J, Sun MY, Han YL.

Exp Cell Res. 2013 May 1;319(8):1165-75. doi: 10.1016/j.yexcr.2013.03.010. Epub 2013 Mar 19.

PMID:
23518389
15.

The role of microRNAs in arterial remodelling.

Nazari-Jahantigh M, Wei Y, Schober A.

Thromb Haemost. 2012 Apr;107(4):611-8. doi: 10.1160/TH11-12-0826. Epub 2012 Feb 28. Review.

PMID:
22371089
16.

Chemokines and microRNAs in atherosclerosis.

Hartmann P, Schober A, Weber C.

Cell Mol Life Sci. 2015 Sep;72(17):3253-66. doi: 10.1007/s00018-015-1925-z. Epub 2015 May 23. Review.

17.

microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression.

Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1562-8. doi: 10.1161/ATVBAHA.110.206201. Epub 2010 May 20.

18.

Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis.

Hakimi M, Peters A, Becker A, Böckler D, Dihlmann S.

J Vasc Surg. 2014 Mar;59(3):794-803. doi: 10.1016/j.jvs.2013.03.048. Epub 2013 Jun 21.

19.

Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.

Liu X, Cheng Y, Yang J, Xu L, Zhang C.

J Mol Cell Cardiol. 2012 Jan;52(1):245-55. doi: 10.1016/j.yjmcc.2011.11.008. Epub 2011 Nov 22.

20.

The magic and mystery of microRNA-27 in atherosclerosis.

Chen WJ, Yin K, Zhao GJ, Fu YC, Tang CK.

Atherosclerosis. 2012 Jun;222(2):314-23. doi: 10.1016/j.atherosclerosis.2012.01.020. Epub 2012 Jan 18. Review.

PMID:
22307089

Supplemental Content

Support Center